Outcomes associated with treatment change from tenofovir disoproxil fumarate to tenofovir alafenamide in HIV‐1‐infected patients: a real‐world study in Japan

OBJECTIVES: To investigate the impact of switching from tenofovir disoproxil fumarate (TDF)‐ to tenofovir alafenamide (TAF)‐containing regimens on bone, kidney, serum lipids and body weight among Asian patients. METHODS: A prospective, multicentre, observational cohort study was conducted at three c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanda, Naoki, Okamoto, Koh, Okumura, Hisatoshi, Mieno, Makiko, Sakashita, Kentaro, Sasahara, Teppei, Hatakeyama, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251761/
https://www.ncbi.nlm.nih.gov/pubmed/33720508
http://dx.doi.org/10.1111/hiv.13061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251761/
https://www.ncbi.nlm.nih.gov/pubmed/33720508
http://dx.doi.org/10.1111/hiv.13061

Ejemplares similares